跳至主要内容
临床试验/ACTRN12616001138471
ACTRN12616001138471招募中未知

Developing novel blood-based DNA and RNA biomarkers to detect adenocarcinoma by assessing the blood from people.aged 25 years and older, who have recently been diagnosed with prostate, breast, lung, pancreas, gallbladder, biliary tract, duodenal, periampullary, oesophageal or stomach cancer.

Erin Symonds0 个研究点目标入组 1,300 人开始时间: 2016年8月22日最近更新:
适应症

试验速览

阶段
未知
状态
招募中
发起方
入组人数
1,300

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Non-randomised trial
主要目的
Diagnosis

入排标准

年龄范围
25 Years 至 o limit(—)
性别
All

入选标准

  • Male or female aged 25 years or more
  • -Known diagnosis of primary adenocarcinoma of the prostate, breast, lung, pancreas, oesophagus, stomach or digestive tract cancers (of any pathological stage)
  • -Ability and willingness to undergo venepuncture procedure
  • -Patients must be capable of providing satisfactory informed consent

排除标准

  • -Unable to provide informed consent.

研究者

发起方
Erin Symonds

相似试验